ANI Pharmaceuticals, Inc.

$81.6
USD
Last updated on --.
24h volume103.56K
24h highest84.1380 USD
24h lowest80.9980 USD
24h Price movement+0.24%

ANIP recent prices

24 Hours
+0.24%+$0.195
30 days
+3.38%+$2.655
60 days
+10.10%+$7.445
90 days
+9.82%+$7.255

Key data

Previous close81.4100 USD
Market cap1.86B USD
Volume103.56K
P/E ratio22.210000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)3.6900 USD
Net income (FY)92.15M USD
Revenue (FY)923.71M USD
Last report dateMay 8, 2026

About ANI Pharmaceuticals, Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersPRINCETON
Employees (FY)970.00
Revenue per employee (FY)952.27K USD
Net income per employee (FY)95.00K USD
Listed onNasdaq
Official website

ANIP conversion tables

ANIPANIP
USDUSD
0.5 ANIP40.8 USD
1 ANIP81.6 USD
5 ANIP408.02 USD
10 ANIP816.05 USD
USDUSD
ANIPANIP
0.5 USD0.0061271 ANIP
1 USD0.012254 ANIP
5 USD0.061271 ANIP
10 USD0.12254 ANIP

FAQ

ANIP is trading at $81.60, +0.24% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ANIP stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ANIP is currently trading at $81.60, +0.24% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ANIP price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ANIP's P/E ratio is currently 22.210000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ANIP; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ANIP's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
ANI Pharmaceuticals, Inc.'s market cap is currently 1.86B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume103.56K
24h highest84.1380 USD
24h lowest80.9980 USD
24h Price movement+0.24%
ANIPANIP
USDUSD
Start trade with ANIP Perpetual